Replenish Raises $10.25M

Pasadena-based Replenish Inc. has quietly raised $10.25M in venture funding, according to a regulatory filing by the firm this week. No details on the firm have been disclosed, however, the firm describes itself as working on a "flexible drug delivery platform". According to the filing, the firm's board members include Sabri Markabi, VP R&D and Chief Medical Officer at Alcon Laboratories, and Mark Humayun, a professor of Opthalmology at the University of Southern California's Doheny Eye Institute. More information »